American Academy of Child and Adolescent Psychiatry 59th Annual Meeting Program Schedule
Please note that this schedule is subject to change.
Home | Search | Browse by Day or Program | Author Index | Browse Exhibitors

New Research Poster Presentation 5.19
Effect of Cognitive Ability On the Safety Profile of Aripiprazole When Used to Treat Irritability Associated with Autistic Disorder
Friday, October 26, 2012
Alan Unis, M.D., Kootenai Medical Center, Coeur d'Alene, ID
Corey Ritchings, PharmD, Bristol-Myers Squibb, Plainsboro, NJ
Kimberly K. Laubmeier, Ph.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ
Ronald N. Marcus, MD, Research and Development, Bristol-Myers Squibb, Wallingford, CT
Robert D. McQuade, PhD, Global Medical and Regulatory Affairs and Scientific Alliances, Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ
James M. Eudicone, MBA, MS, Bristol-Myers Squibb, Plainsboro, NJ
Raymond Mankoski, M.D., Ph.D., Research and Development, Bristol-Myers Squibb, Plainsboro, NJ
See more of: New Research Poster Session 5
See more of: New Research Poster
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.